Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2019 Dec 01;17624:4760-4772. doi: 10.1111/bph.14843.
Show Gene links
Show Anatomy links
Binding site location on GABAA receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo.
Kent DE
,
Savechenkov PY
,
Bruzik KS
,
Miller KW
.
???displayArticle.abstract???
BACKGROUND AND PURPOSE: General anaesthetics can act on synaptic GABAA receptors by binding to one of three classes of general anaesthetic sites. Canonical drugs that bind selectively to only one class of site are etomidate, alphaxalone, and the mephobarbital derivative, R-mTFD-MPAB. We tested the hypothesis that the general anaesthetic potencies of mixtures of such site-selective agents binding to the same or to different sites would combine additively or synergistically respectively.
EXPERIMENTAL APPROACH: The potency of general anaesthetics individually or in combinations to cause loss of righting reflexes in tadpoles was determined, and the results were analysed using isobolographic methods.
KEY RESULTS: The potencies of combinations of two or three site-selective anaesthetics that all acted on a single class of site were strictly additive, regardless of which single site was involved. Combinations of two or three site-selective anaesthetics that all bound selectively to different sites always interacted synergistically. The strength of the synergy increased with the number of separate sites involved such that the percentage of each agent's EC50 required to cause anaesthesia was just 35% and 14% for two or three sites respectively. Propofol, which binds non-selectively to the etomidate and R-mTFD-MPAB sites, interacted synergistically with each of these agents.
CONCLUSIONS AND IMPLICATIONS: The established pharmacology of the three anaesthetic binding sites on synaptic GABAA receptors was sufficient to predict whether a mixture of anaesthetics interacted additively or synergistically to cause loss of righting reflexes in vivo. The principles established here have implications for clinical practice.
Alexander,
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.
2017, Pubmed
Alexander,
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.
2017,
Pubmed
Alexander,
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels.
2017,
Pubmed
Amlong,
Contrasting Effects of the γ-Aminobutyric Acid Type A Receptor β3 Subunit N265M Mutation on Loss of Righting Reflexes Induced by Etomidate and the Novel Anesthetic Barbiturate R-mTFD-MPAB.
2016,
Pubmed
Belelli,
The in vitro and in vivo enantioselectivity of etomidate implicates the GABAA receptor in general anaesthesia.
2003,
Pubmed
,
Xenbase
Belelli,
The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid.
1997,
Pubmed
,
Xenbase
Borowicz,
Interactions between non-barbiturate injectable anesthetics and conventional antiepileptic drugs in the maximal electroshock test in mice--an isobolographic analysis.
2004,
Pubmed
Cao,
Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam.
2018,
Pubmed
,
Xenbase
Changeux,
The concept of allosteric interaction and its consequences for the chemistry of the brain.
2013,
Pubmed
Chen,
11-trifluoromethyl-phenyldiazirinyl neurosteroid analogues: potent general anesthetics and photolabeling reagents for GABAA receptors.
2014,
Pubmed
,
Xenbase
Chen,
Structural basis of neurosteroid anesthetic action on GABAA receptors.
2018,
Pubmed
,
Xenbase
Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed
Chiara,
General Anesthetic Binding Sites in Human α4β3δ γ-Aminobutyric Acid Type A Receptors (GABAARs).
2016,
Pubmed
Clarke,
Potency of mixtures of general anaesthetic agents.
1978,
Pubmed
Cotten,
Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.
2010,
Pubmed
,
Xenbase
Curtis,
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.
2018,
Pubmed
Drexler,
Synergistic Modulation of γ-Aminobutyric Acid Type A Receptor-Mediated Synaptic Inhibition in Cortical Networks by Allopregnanolone and Propofol.
2016,
Pubmed
Eger,
Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats.
2008,
Pubmed
Forman,
Mapping General Anesthetic Sites in Heteromeric γ-Aminobutyric Acid Type A Receptors Reveals a Potential For Targeting Receptor Subtypes.
2016,
Pubmed
Forman,
Anesthetic sites and allosteric mechanisms of action on Cys-loop ligand-gated ion channels.
2011,
Pubmed
Forman,
Direct interactions of anesthetics and nonanesthetics with the nicotinic acetylcholine receptor pore.
1998,
Pubmed
Germann,
Activation and modulation of recombinant glycine and GABAA receptors by 4-halogenated analogues of propofol.
2016,
Pubmed
,
Xenbase
Harding,
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
2018,
Pubmed
Hendrickx,
Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility.
2008,
Pubmed
Hosie,
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites.
2006,
Pubmed
Husain,
2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.
2003,
Pubmed
,
Xenbase
Jones,
Propofol-thiopentone admixture-hypnotic dose, pain on injection and effect on blood pressure.
1999,
Pubmed
Jurd,
General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.
2003,
Pubmed
Kent,
Binding site location on GABA<sub>A</sub> receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo.
2020,
Pubmed
,
Xenbase
Kilkenny,
Animal research: reporting in vivo experiments: the ARRIVE guidelines.
2010,
Pubmed
Laverty,
Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites.
2017,
Pubmed
Laverty,
Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer.
2019,
Pubmed
Leeb-Lundberg,
Barbiturate receptor sites are coupled to benzodiazepine receptors.
1980,
Pubmed
Li,
The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptors.
2014,
Pubmed
,
Xenbase
McKay,
Synergism among i.v. anaesthetics.
1991,
Pubmed
Miller,
Structural basis for GABAA receptor potentiation by neurosteroids.
2017,
Pubmed
Nelson,
Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase
Nicoll,
Prolongation of hippocampal inhibitory postsynaptic potentials by barbiturates.
1975,
Pubmed
Olsen,
Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
2015,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Richards,
Additive and non-additive effects of mixtures of short-acting intravenous anaesthetic agents and their significance for theories of anaesthesia.
1981,
Pubmed
Rüsch,
Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation.
2004,
Pubmed
,
Xenbase
Savechenkov,
Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic.
2012,
Pubmed
Shin,
Propofol Is an Allosteric Agonist with Multiple Binding Sites on Concatemeric Ternary GABAA Receptors.
2018,
Pubmed
,
Xenbase
Shin,
Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites.
2019,
Pubmed
,
Xenbase
Shin,
The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity.
2017,
Pubmed
,
Xenbase
Siegwart,
Mutational analysis of molecular requirements for the actions of general anaesthetics at the gamma-aminobutyric acidA receptor subtype, alpha1beta2gamma2.
2003,
Pubmed
Stastna,
Neurosteroid analogues. 16. A new explanation for the lack of anesthetic effects of δ(16)-alphaxalone and identification of a δ(17(20)) analogue with potent anesthetic activity.
2011,
Pubmed
,
Xenbase
Szabo,
Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites.
2019,
Pubmed
,
Xenbase
Tallarida,
The interaction index: a measure of drug synergism.
2002,
Pubmed
Tallarida,
Drug Combinations: Tests and Analysis with Isoboles.
2016,
Pubmed
Vinik,
Isobolographic analysis of propofol-thiopental hypnotic interaction in surgical patients.
1999,
Pubmed
Waud,
On biological assays involving quantal responses.
1972,
Pubmed
Wongsamitkul,
Toward Understanding Functional Properties and Subunit Arrangement of α4β2δ γ-Aminobutyric Acid, Type A (GABAA) Receptors.
2016,
Pubmed
,
Xenbase
Ziemba,
Alphaxalone Binds in Inner Transmembrane β+-α- Interfaces of α1β3γ2 γ-Aminobutyric Acid Type A Receptors.
2018,
Pubmed
,
Xenbase
Zolle,
New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.
2008,
Pubmed
